Author: Sree Roy

This Winning Biotech Stock Looks Like a Buy

Strong growth in Jazz Pharmaceuticals’ narcolepsy drug Xyrem makes The Motley Fool believe the good times will continue to roll. Xyrem is fast approaching blockbuster status, as sales grew 37% in 2014 to more than $770...

Read More

Neuronal Plasticity Helps Run Biological Clock

A team of scientists has linked changes in the structure of a handful of central brain neurons to understanding how animals adjust to changing seasons. Its findings enhance our understanding of the mechanisms vital to the...

Read More